Related Experiment Video
Updated: Jul 21, 2025

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
Cardiac Function and Serum Biomarkers throughout Staged Fontan Palliation: A Prospective Observational Study
J P G van der Ven1,2,3, V P Kamphuis2,4, E van den Bosch1,2
1Division of Pediatric Cardiology, Department of Pediatrics, Erasmus MC Sophia Children's Hospital, 3015 CN Rotterdam, The Netherlands.
Fontan palliation surgery temporarily reduces ventricular function in some patients, but biomarkers don't predict outcomes. Further research is needed to understand these complex cardiac changes.
Area of Science:
- Cardiology
- Biomarker Research
- Pediatric Cardiac Surgery
Background:
- Fontan palliation involves multiple surgeries, impacting ventricular function.
- Cardiopulmonary bypass and volume unloading effects on cardiac function are not fully understood.
- Understanding biological processes in Fontan patients is crucial for improving care.
Purpose of the Study:
- To investigate biological processes affecting ventricular function and recovery post-Fontan palliation.
- To describe changes in ventricular function due to volume unloading during Fontan palliation.
- To identify biomarkers related to ventricular function and recovery in Fontan patients.
Main Methods:
- Prospective, multicenter observational study.
- Included patients undergoing partial (PCPC) or total cavo-pulmonary connection (TCPC).
- Assessed echocardiography and serum biomarkers (OLINK CVD-III) at three time points.
Main Results:
- Single ventricular longitudinal strain (SV GLS) temporarily decreased post-PCPC, but not post-TCPC.
- Biomarker analysis revealed four principal components (PCs); PC2 (superoxide anion regulation) increased post-surgery.
- No identified biomarker PCs correlated with ventricular performance or clinical outcomes.
Conclusions:
- SV GLS is temporarily impaired after PCPC, highlighting surgical impact.
- Biomarkers reflect post-operative stress and adaptation but do not predict outcomes.
- Further research is needed to link biomarkers to ventricular function and recovery in Fontan patients.
More Related Videos
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiomyopathy VI: Nursing Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Mitral Stenosis IV: Nursing Management